https://www.idival.org/wp-content/uploads/2022/05/cab-presentacion.jpg

An international study questions the routine use of beta-blockers after a heart attack in patients with a residual ejection fraction greater than 50%

8 de October de 2025

The REBOOT trial concludes, published in “The New England Journal of Medicine”, with the participation of Dr. José María de la Torre Hernández, Head of Cardiology at Valdecilla Hospital One of the most widespread practices in modern cardiology—the routine use of beta-blockers after a myocardial infarction—has been called into question thanks to the results of […]

Read more →

NEXT-Val awards seven young researchers driving biomedical science from Cantabria

6 de October de 2025

The Valdecilla Health Research Institute (IDIVAL) has recognized seven young researchers through the NEXT-Val program (NEXT generation VALdecilla), created to promote translational research and support the careers of emerging scientists in Cantabria’s biomedical field. The call, with nearly €150,000 in funding, offers up to €25,000 per project for a maximum duration of two years. It […]

Read more →

IDIVAL convenes a Technical-Healthcare Meeting of the SAM Project on October 7: a first step towards social prescribing with a digital twin

4 de October de 2025

Under the coordination of Olga De Cos, researcher from the Health Economics group at the Marqués de Valdecilla Research Institute (IDIVAL), the European project Social Assets Mapping (SAM), part of the Interreg Sudoe network, will hold its Inaugural Technical-Healthcare Meeting next Tuesday, October 7, at the Marqués de Valdecilla University Hospital (HUMV). This is the […]

Read more →

IDIVAL and Nebrija University launch the 4th edition of the MINDS Master’s in Health Innovation

3 de October de 2025

The Health Research Institute of Cantabria (IDIVAL) and Nebrija University inaugurated a new edition of the Master’s in Health Innovation Management and Leadership (MINDS) at the Fundación Botín headquarters in Madrid. Since 2021, this pioneering program has trained professionals to lead change in the healthcare sector. The opening event brought together representatives from organizations supporting […]

Read more →

Santander to host i-Days 2025, health innovation days for students organized by IDIVAL

2 de October de 2025

Santander will host a new edition of the Innovation Days (i-Days) on October 22 and 23, an initiative promoted by EIT Health—one of the largest EU-funded health initiatives—aimed at fostering innovation in healthcare through the active participation of students from different academic fields. The event, organized by the Marqués de Valdecilla University Hospital (IDIVAL) in […]

Read more →

IDIVAL encourages participation in “La Caja”, a solidarity project in support of childhood cancer research

1 de October de 2025

The Health Research Institute of Cantabria (IDIVAL) joins the solidarity initiative “La Caja”, taking place at Santander’s City Hall Square from September 27 to October 5, led by Cantabrian illusionists Mago Xuso and Asier Moon. For nine days, the artists will remain enclosed in a semi-transparent room installed in the city center, in a symbolic […]

Read more →

IDIVAL hosted the visit of research managers within the REGIC mobility program

30 de September de 2025

The Valdecilla Health Research Institute (IDIVAL) welcomed the visit of Antonio Ortega Llamas, Innovation and Technology Transfer Officer at the Maimónides Institute for Biomedical Research of Córdoba (IMIBIC), and José Francisco Galve Agudo, Post-Award Project Management Officer at the Aragón Health Research Institute (IIS Aragón). This stay was part of the Mobility Program for Managers […]

Read more →

IDIVAL launches two free online courses in Cantabria under the European JACARDI project to tackle cardiovascular disease and diabetes

29 de September de 2025

The Health Research Institute of Cantabria (IDIVAL), through its Nursing Research Group, will launch on October 1st two free seven-week online courses within the framework of the European JACARDI project, a joint action aimed at laying the foundations for the new European Union strategy against cardiovascular disease and diabetes. The courses are supervised by professionals […]

Read more →

IDIVAL participated in the European project Health4EUkids meeting in Patras (Greece)

25 de September de 2025

The Valdecilla Health Research Institute (IDIVAL) took part in the meeting held in Patras (Greece) within the framework of the Health4EUkids project, a Joint Action co-funded by the European Commission through the EU4Health program. This was the third-to-last working meeting of the international consortium, which brings together representatives from 12 European countries to advance the […]

Read more →

IDIVAL drives the AECC challenge of achieving 70% survival by 2030 through its seven oncology research groups

24 de September de 2025

On the occasion of World Cancer Research Day, the Spanish Association Against Cancer (AECC) highlights the need to move toward patient-centered research as a fundamental strategy to overcome oncology’s greatest challenge: achieving a 70% survival rate by 2030 and ensuring a better quality of life for people with cancer. The Marqués de Valdecilla Research Institute […]

Read more →